Filing Details

Accession Number:
0001209191-23-027770
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-05 17:03:01
Reporting Period:
2023-05-03
Accepted Time:
2023-05-05 17:03:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645569 Dice Therapeutics Inc. DICE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638944 Kevin Judice C/O Dice Therapeutics, Inc.
400 East Jamie Court, Suite 300
South San Francisco CA 94080
Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-03 13,698 $36.50 799,685 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 28, 2022.